A study on usefulness and safety of donepezil for cognitive function and phychological symptoms of patients with Parkinson's disease and Alzheimer type dementia.

A study on usefulness and safety of donepezil for cognitive function and phychological symptoms of patients with Parkinson's disease and Alzheimer type dementia. - Donepezil study on Parkinson\'s disease with dementia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010752

Enrollment

Registered

2013-05-17

Start date

2013-05-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

donepezil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Parkinson's disease and were noticed to have symptoms of dementia. 1)Outpatients of Department of Neurology, Kansai Medical University. 2)Those who aggreed to participate in this study

Exclusion criteria

Exclusion criteria: 1)Patients or their families disagreed to this study 2)Who have been already treated with anti-dementia drugs. 3)Past medical history of severe neurological or psychological disorders (brain tumor, schizophrenia, epilepsy, normal pressure hydrocephalus, mental retardation, head injury associated with loss of consciousness, neurosurgery with residual symptoms). 4)Who have been regarded to be inappropriate to participate in the study.

Design outcomes

Primary

Measure	Time frame
UPDRS,MMSE	—

Countries

Japan

Contacts

Public ContactSatoshi Kaneko

Kansai Medical University Department of Neurology

kanekosa@takii.kmu.ac.jp072-804-2542

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

A study on usefulness and safety of donepezil for cognitive function and phychological symptoms of patients with Parkinson&#39;s disease and Alzheimer type dementia.